Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 6Carcinoma, Renal Cell 6Sarcoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 3Kidney Neoplasms 3Glioma 3Colonic Neoplasms 3Wilms Tumor 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Rectal Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Neoplasms 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lung Neoplasms 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Hematologic Neoplasms 2Ependymoma 2Endometrial Neoplasms 2

Interventions

Radiotherapy 4Docetaxel 4Trastuzumab 3Psychiatric Rehabilitation 3cediranib 2Therapeutics 2Standard of Care 2Radiosurgery 2Physical Therapy Modalities 2Early Intervention, Educational 2Cyclophosphamide 2vandetanib 1tipifarnib 1temsirolimus 1sargramostim 1palbociclib 1orantinib 1interleukin-4-Pseudomonas exotoxin 1entinostat 1X-Ray Therapy 1Watchful Waiting 1Vorinostat 1Vinorelbine 1Thiotepa 1Thalidomide 1Sirolimus 1Practice Guidelines as Topic 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × palbociclib × Genitourinary × Clear all
NCT01037790 2021-03-11

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
304 enrolled 12 charts
BreastDermatologicGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Melanoma, Rectal Neoplasms, Teratoma, Testicular Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡